Sustained virological responses (SR; PCR negative 24 weeks after treatment cessation) in naive patients taken from the two multicentre randomised controlled trials published in 1998144 145
| SR | |||||
| IFN/placebo | IFN/ribavirin | ||||
| Study | 24 weeks | 48 weeks | 24 weeks | 48 weeks | |
| Poynard144 (n=832) | — | 53/278 (19%) | 96/277 (35%) | 118/277 (43%) | |
| McHutchinson145(n=681) | 13/231 (6%) | 29/225 (13%) | 70/228 (31%) | 87/228 (38%) | |
| Total (n=1513) | 13/231 (6%) | 82/503 (16%) | 166/505 (33%) | 205/505 (41%) | |